Delayed-onset cord1 progressive retinal atrophy in English Springer Spaniels genetically affected with the RPGRIP1 variant.

Autor: Kwok JC; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Sato Y; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Niggel JK; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ozdogan E; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Murgiano L; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Miyadera K; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publikováno v: Veterinary ophthalmology [Vet Ophthalmol] 2024 Oct 20. Date of Electronic Publication: 2024 Oct 20.

Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii.

Autor: Maehara Y; Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, 815-8588, Japan. maehara@kyushu.kouritu.or.jp., Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Ota M; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Harimoto N; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, 371-8511, Japan., Ando K; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Nakanishi R; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Kawazoe T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Fujimoto Y; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Nonaka K; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Kitao H; Oral Medicine Research Center, Fukuoka Dental College, Fukuoka, 814-0193, Japan.; Department of Molecular Cancer Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Iimori M; Oral Medicine Research Center, Fukuoka Dental College, Fukuoka, 814-0193, Japan.; Department of Molecular Cancer Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Makino K; Division of Clinical Development and Medical Affairs, Taiho Pharmaceutical Co. Ltd, Tokyo, 101-8444, Japan., Takechi T; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd, Tsukuba, 300-2611, Japan., Sagara T; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd, Tsukuba, 300-2611, Japan., Miyadera K; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd, Tsukuba, 300-2611, Japan., Matsuoka K; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd, Tsukuba, 300-2611, Japan., Tsukihara H; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd, Tsukuba, 300-2611, Japan., Kataoka Y; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd, Tsukuba, 300-2611, Japan., Wakasa T; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd, Tsukuba, 300-2611, Japan., Ochiiwa H; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd, Tsukuba, 300-2611, Japan., Kamahori Y; Division of Clinical Development and Medical Affairs, Taiho Pharmaceutical Co. Ltd, Tokyo, 101-8444, Japan., Tokunaga E; Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1347, Japan., Saeki H; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, 371-8511, Japan., Yoshizumi T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan., Kakeji Y; Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan., Shirabe K; Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, 371-8511, Japan., Baba H; Department of Gastroenterological Surgery, Kumamoto University, 1-1-1, Honjyo, Chuo-Ku, Kumamoto, 860-8556, Japan., Shimada M; Department of Surgery, Tokushima University, 3-18-15 Kuramoto-Cho, Tokushima, 770-8503, Japan.

Publikováno v: International journal of clinical oncology [Int J Clin Oncol] 2023 May; Vol. 28 (5), pp. 613-624. Date of Electronic Publication: 2023 Mar 24.

The anti-tumor effect of trifluridine via induction of aberrant mitosis is unaffected by mutations modulating p53 activity.

Autor: Wakasa T; Department of Molecular Cancer Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.; Taiho Pharmaceutical Co. Ltd., Tokyo, Japan.; Department of Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan., Nonaka K; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan., Harada A; Division of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan., Ohkawa Y; Division of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan., Kikutake C; Division of Bioinformatics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan., Suyama M; Division of Bioinformatics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan., Kobunai T; Taiho Pharmaceutical Co. Ltd., Tokyo, Japan., Tsunekuni K; Taiho Pharmaceutical Co. Ltd., Tokyo, Japan., Matsuoka K; Taiho Pharmaceutical Co. Ltd., Tokyo, Japan., Kataoka Y; Taiho Pharmaceutical Co. Ltd., Tokyo, Japan., Ochiiwa H; Taiho Pharmaceutical Co. Ltd., Tokyo, Japan., Miyadera K; Taiho Pharmaceutical Co. Ltd., Tokyo, Japan., Sagara T; Taiho Pharmaceutical Co. Ltd., Tokyo, Japan., Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Ohdo S; Department of Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan., Maehara Y; Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan., Iimori M; Department of Molecular Cancer Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. iimorim@fdcnet.ac.jp.; Oral Medicine Research Center, Fukuoka Dental College, Fukuoka, Japan. iimorim@fdcnet.ac.jp., Kitao H; Department of Molecular Cancer Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. kitaoh@fdcnet.ac.jp.; Oral Medicine Research Center, Fukuoka Dental College, Fukuoka, Japan. kitaoh@fdcnet.ac.jp.

Publikováno v: Cell death discovery [Cell Death Discov] 2024 Jul 02; Vol. 10 (1), pp. 307. Date of Electronic Publication: 2024 Jul 02.

A naturally occurring canine model of syndromic congenital microphthalmia.

Autor: Murgiano L; Department of Clinical Sciences & Advanced Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Sylvia M. Van Sloun Laboratory for Canine Genomic Analysis, University of Pennsylvania, Philadelphia, PA 19104, USA., Banjeree E; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., O'Connor C; Section of Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; East Bridgewater Veterinary Hospitla, East Bridgewater, MA 02333, USA., Miyadera K; Department of Clinical Sciences & Advanced Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Werner P; Section of Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Genetic Diagnostic Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Niggel JK; Department of Clinical Sciences & Advanced Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Sylvia M. Van Sloun Laboratory for Canine Genomic Analysis, University of Pennsylvania, Philadelphia, PA 19104, USA., Aguirre GD; Department of Clinical Sciences & Advanced Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Sylvia M. Van Sloun Laboratory for Canine Genomic Analysis, University of Pennsylvania, Philadelphia, PA 19104, USA., Casal ML; Department of Clinical Sciences & Advanced Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Section of Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Publikováno v: G3 (Bethesda, Md.) [G3 (Bethesda)] 2024 Jun 05; Vol. 14 (6).

Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.

Autor: Akita T; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Ariyasu R; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Kakuto S; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Miyadera K; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Kiritani A; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Tsugitomi R; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Amino Y; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Uchibori K; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Kitazono S; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Yanagitani N; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Tasaka S; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Publikováno v: Thoracic cancer [Thorac Cancer] 2024 Apr; Vol. 15 (10), pp. 788-796. Date of Electronic Publication: 2024 Feb 24.